Hanson Wade
Boston
About This Business
Hanson Wade is a leading organizer of specialized events and conferences in the field of cytokine-based drug development. The company brings together influential leaders and experts from top biotechnology and pharmaceutical companies to discuss and address the challenges and opportunities in the development of cytokine-based therapies. Their events, such as the Cytokine-Based Drug Development Summit, provide a platform for intimate discussions, interactive workshops, and presentations to drive innovation and break down barriers associated with systemic toxicity. By improving the specificity and delivery of cytokine-based drugs, Hanson Wade's events help influence the future of immunotherapy. With a strong network of partners, including Candel, Deka Biosciences, Regeneron, Sanofi, ModeX, and OSE, Hanson Wade is at the forefront of advancing cytokine-based therapies and facilitating collaboration among key stakeholders. The company's expertise and commitment to the field have made it a trusted name in the industry, and its events are highly anticipated by professionals seeking to stay updated on the latest developments and advancements in cytokine-based drug development. As the field continues to evolve, Hanson Wade remains dedicated to providing a platform for knowledge sharing, innovation, and progress, ultimately contributing to the development of more effective and targeted treatments for various diseases.
Categories
Customer Reviews
1 total reviews
Eleanor Waverley
June 06, 2025Underwhelming Experience at the Cytokine-Based Drug Development Summit
I attended the Cytokine-Based Drug Development Summit organized by Hanson Wade, expecting a platform for meaningful discussions and innovative ideas. Unfortunately, the event felt overly commercialized, with too much focus on the interests of the partnering companies rather than the advancement of cytokine-based therapies. The presentations, while informative, lacked depth and failed to address the systemic toxicity challenges adequately. The workshops, intended to be interactive, were poorly moderated and did not foster the kind of collaborative environment I had hoped for. Given the prestige of the attending companies and the potential of the field, I was disappointed by the lack of breakthrough discussions or revelations. For an event that promises to influence the future of immunotherapy, it seemed more like a networking opportunity for big pharma than a genuine attempt to drive innovation. Perhaps with a more balanced approach, prioritizing scientific progress over corporate interests, Hanson Wade's events could live up to their promise of advancing cytokine-based drug development.
Is this your company?
Take control of your business profile and manage customer reviews.
What you get:
- Manage your business profile
- View all customer reviews
- Option to remove inappropriate reviews
- Priority support
Review Statistics
Based on 1 reviews
Company Information
Address
Boston